Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1998

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

DRUG

chemotherapy

DRUG

efaproxiral

DRUG

paclitaxel

RADIATION

radiation therapy

Trial Locations (16)

12208

Cancer Center of Albany Medical Center, Albany

21287

Johns Hopkins Oncology Center, Baltimore

37205

Dan Rudy Cancer Center, Nashville

38119

Boston Cancer Group, Memphis

40202

James Graham Brown Cancer Center, Louisville

44195

Cleveland Clinic Cancer Center, Cleveland

85724

Arizona Cancer Center, Tucson

90048

Cedars-Sinai Comprehensive Cancer Center, Los Angeles

37232-6838

Vanderbilt Cancer Center, Nashville

23298-0037

Massey Cancer Center, Richmond

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

J1H 5N4

Centre Universitaire de Sante de l'Estrie - Site Fleurimont, Fleurimont

H3G 1A4

Montreal General Hospital, Montreal

H3T 1E2

Jewish General Hospital - Montreal, Montreal

H4L 2M1

Notre Dame Hospital, Montreal

All Listed Sponsors
lead

Spectrum Pharmaceuticals, Inc

INDUSTRY

NCT00004202 - Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter